References
- Schechter R, Torfs CP, Bateson TF. The epidemiology of infantile hypertrophic pyloric stenosis. Paediatr Perinat Epidemiol 1997; 11: 407–27.
- Rasmussen L, Green A, Hansen LP. The epidemiology of infantile hypertrophic pyloric stenosis in a Danish population, 1950–84. Int J Epidemiol 1989; 18: 413–7.
- Rollins MD, Shields MD, Quinn RJM, Wooldridge MAW. Pyloric stenosis: congenital or acquired? Arch Dis Child 1989; 64: 138–47.
- SanFilippo JA. Infantile hypertrophic pyloric stenosis related to ingestion of erythromycin estolate: a report of five cases. J Pediatr Surg 1976; 11: 177–80.
- Stang H. Pyloric stenosis associated with erythromycin ingested through breastmilk. Minn Med 1986; 69: 669–70, 682.
- Honein MA, Paulozzi LJ, Himelright IM, Lee B, Cragan JD, Patterson L, et al. Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: a case review and cohort study. Lancet 1999; 354: 2101–5.
- Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin – Knoxville, Tennessee, 1999. Morb Mortal Wkly Rep 1999; 48: 1117–20.
- Mahon BE, Rosenman MB, Kleiman MB. Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis. J Pediatr 2001; 139: 380–4.
- Cooper WO, Griffin MR, Arbogast P, Hickson GB, Gautam S, Ray WA. Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis. Arch Pediatr Adolesc Med 2002; 156: 647–50.
- Louik C, Werler MM, Mitchell AA. Erythromycin use during pregnancy in relation to pyloric stenosis. Am J Obstet Gynecol 2002; 186: 288–90.
- Cooper WO, Ray WA, Griffin MR. Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis. Obstet Gynecol 2002; 100: 101–6.
- Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. Baltimore, MD: Williams & Wilkins, 1998: 394–5.
- Nielsen GL, Sørensen HT, Larsen H, Pedersen L. Safety of nonsteroid anti-inflammatory drugs in pregnancy: a cohort study with 1462 exposed pregnancies. Br Med J 2001; 322: 266–70.
- Sorensen HT, Nørgård B, Pedersen L, Larsen H, Johnsen SP. Maternal smoking and risk of hypertrophic infantile pyloric stenosis: a 10-year population-based cohort study. Br Med J (in press).
- EuroMap Group, Rockenbauer M, Olsen J, Czeizel AE, Pedersen L, Sorensen HT. Recall bias in a case – control surveillance system on the use of medicine during pregnancy. Epidemiology 2001; 12: 461–6.
- Hansen AM, Udsen M. Sundhedsplejen og småbørns-familierne: en brugerundersøgelse. (Public health and families with young children: a user survey) Copenhagen: Sund-hedsstyrelsen og Munksgaard; 1994.
- Larsen H, Nielsen GL, Bendsen J, Flint C, Olsen J, Sørensen HT. Predictive value and completeness of the registration of congenital abnormalities in three Danish population-based registries. Scand J Public Health (in press).
- Peeters TL. Erythromycin and other macrolides as prokinetic agents. Gastroenterology 1993; 105: 1886–99.
- Jadcherla SR, Klee G, Berseth CL. Regulation of migrating motor complexes by motilin and pancreatic polypeptide in human infants. Pediatr Res 1997; 42: 365–9.
- Di Lorenzo C, Flores AF, Tomomasa T, Hyman PE. Effect of erythromycin on antroduonal motility in children with chronic functional gastrointestinal symptoms. Dig Dis Sci 1994; 39: 1399–404.